Ze-Qi Xu

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL.

Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million.

Part of Formosa Laboratories, Inc., Synchem-Formosa is a company that engages in research and development of organic synthesis, medicinal chemistry, and pharmaceuticals. The company is based in Elk Grove Village, IL. The company was founded by Daniel Fang and Ze-Qi Xu. The CEO is W. Paul Mar. Synchem-Formosa was acquired by Formosa Laboratories, Inc. on June 03, 2024.